HomeTRML • NASDAQ
add
Tourmaline Bio Inc
Previous close
$17.32
Day range
$16.54 - $17.61
Year range
$11.56 - $29.79
Market cap
433.81M USD
Avg Volume
397.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.81M | 73.31% |
Net income | -22.24M | -72.34% |
Net profit margin | — | — |
Earnings per share | -0.86 | -6.17% |
EBITDA | -25.80M | -73.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 258.30M | 27.27% |
Total assets | 309.00M | 46.94% |
Total liabilities | 8.95M | 70.36% |
Total equity | 300.05M | — |
Shares outstanding | 25.69M | — |
Price to book | 1.48 | — |
Return on assets | -20.24% | — |
Return on capital | -20.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.24M | -72.34% |
Cash from operations | -20.89M | -123.34% |
Cash from investing | 16.39M | 320.90% |
Cash from financing | -3.00K | -100.00% |
Net change in cash | -4.50M | -107.18% |
Free cash flow | -11.45M | -29.82% |
About
Founded
2021
Website
Employees
74
